Through communication with the physician we were able to learn that the fogarty catheter was about 1/3 inflated upon removal through the patch.Additionally, the user was removing clot material from the vessel, thereby increasing surface area of material that was passing through the graftotomy along with the expanded balloon.It is likely that this excess material led to strain on the graftotomy area and created a tear.Our device tracing system was able to determine that the user had also implanted several other patches from this same lot without any reported issues.Our lot history review did not discover any issues related to the manufacturing or packaging of this lot.Our investigation, including consultation with our medical director, concluded that this issue was likely due to operator influence and that the device was not likely the cause of the issue.The report was initially submitted on 02aug2016 through mail.However, on 8/16/2016 we received letter from fda to submit the form electronically.
|
The customer reported that during a femoral endarterectomy procedure with patching, the device experienced a transverse tear.The physician intervened by performing a graftotomy ( cutting of the patch ) and passing of a 4f fogarty catheter to clear the obstructions both proximally and distally to the graft site.After passing the fogarty repeatedly thought the graftotomy site, the patch experienced a transverse tear to the suture line.Doctor removed patch and discarded, replaced with another patch.
|